JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M109396200 on October 9, 2001

J. Biol. Chem., Vol. 276, Issue 52, 49125-49132, December 28, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/52/49125    most recent
M109396200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersen, P. S.
Right arrow Articles by Karjalainen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, P. S.
Right arrow Articles by Karjalainen, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Response Calculus for Immobilized T Cell Receptor Ligands*

Peter S. AndersenDagger §, Charlotte MennéDagger , Roy A. Mariuzza, Carsten GeislerDagger , and Klaus Karjalainen||

From the Dagger  Institute for Medical Microbiology and Immunology, University of Copenhagen, The Panum Institute, Bldg. 24.2, Blegdamsvej 3C, Copenhagen DK-2200, Denmark, the  Center for Advanced Research in Biotechnology, University of Maryland, Rockville, Maryland 20850, and the || Basel Institute of Immunology, Grenzsacherstrasse 487, postfach CH-4005, Basel, Switzerland

Received for publication, September 28, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To address the molecular mechanism of T cell receptor (TCR) signaling, we have formulated a model for T cell activation, termed the 2D-affinity model, in which the density of TCR on the T cell surface, the density of ligand on the presenting surface, and their corresponding two-dimensional affinity determine the level of T cell activation. When fitted to T cell responses against purified ligands immobilized on plastic surfaces, the 2D-affinity model adequately simulated changes in cellular activation as a result of varying ligand affinity and ligand density. These observations further demonstrated the importance of receptor cross-linking density in determining TCR signaling. Moreover, it was found that the functional two-dimensional affinity of TCR ligands was affected by the chemical composition of the ligand-presenting surface. This makes it possible that cell-bound TCR ligands, despite their low affinity in solution, are of optimal two-dimensional affinity thereby allowing effective TCR binding under physiological conditions, i.e. at low ligand densities in cellular interfaces.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Most T cells present alpha beta T cell receptors (TCR)1 on their surface. The natural ligands for these receptors are small antigenic peptides bound to MHC molecules (pep·MHC) on the surface of other cells with which T cells interact (1). Antigen recognition can result in various protective functions, including release of cytokines to cause local inflammation and specific killing of virus-infected cells (2).

The TCR comprises the alpha /beta subunits that recognize pep·MHC and the signal-transducing subunits delta , epsilon , gamma , and zeta  (CD3-zeta complex), which contain the immunoreceptor tyrosine-based activation motifs (ITAMs) (3). Signaling of the TCR·CD3-zeta complex can be viewed as a dynamic phosphorylation/dephosphorylation equilibrium of ITAMs where the steady-state levels of phosphorylated ITAMs are low in unstimulated T cells (4). The molecular mechanism by which ligand-bound TCR perturbs this equilibrium is unknown.

One way to help identify the molecular features underlying TCR signaling is to develop mathematical models capable of simulating TCR signaling. Describing TCR signaling as a dynamic equilibrium indicates that it should be possible to model T cell behavior using mathematical expressions involving the binding constants of TCR·ligand interactions. Moreover, as recently discussed (5), such models are attractive because they allow for simulation of T cell responses and thus help guide future research, and because they can assist in optimizing clinical immunomodulatory strategies.

Previous mathematical analysis of T cell responses have been successful in modeling specific features such as fast ligand dissociation kinetics (6), peptide antagonism (7, 8), rate of receptor internalization (9), or the effect of co-stimulation on proliferation (10). Current models favor a discrimination between the potency of TCR ligands based on the life-time of the interaction, i.e. the off-rate (6, 7, 9). In Support, recent studies suggest that TCR signaling correlates to ligand dissociation rate (11-13). This is, however, still a matter of controversy, because conflicting reports exists, which favor ligand affinity as the determining factor for TCR signaling (14-20).

Recently, we have compared the stimulatory efficacy of a panel of anti-TCR antibodies and a panel of superantigens varying 10,000- and 150-fold in TCR affinity, respectively, with corresponding changes in binding kinetics as well (20). Stimulation of T cells with ligand-coated plastic surfaces revealed that the biological activity primarily matched the affinity of the TCR·ligand interaction. It therefore appeared that it was the density of bound receptors in the contact area that determined the strength of the T cell stimulus. This prompted us to develop a theoretical framework in which T cell responsiveness was expressed in mathematical terms. We present here a mathematical model, termed the 2D-affinity model, that allows for direct computation of T cell responses based on receptor and ligand densities and their corresponding solution affinity.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Lymphocytes and T Cell Lines-- A5 T cell hybridomas expressing the 14.3.d TCR (I-Ed/HA 110-119; Valpha 4.2, Vbeta 8.2) and carrying the reporter gene plasmid were grown in the presence of 0.5 mg/ml hygromycin (Calbiochem, La Jolla, CA) and cultured in RPMI 1640 medium supplemented with penicillin, 2 × 105 units/liter (Leo Pharmaceutical Products, Ballerup, Denmark), streptomycin, 50 µg/ml (Merck, Darmstadt, Germany), and 10% (v/v) fetal calf serum (Life Technologies Inc., Paisley, UK) at 37 °C in 5% CO2.

Protein Expression and Purification-- Antibodies and I-Ed chimeras were produced in Drosophila cells basically as previously described (21). The recombinant protein was purified from culture supernatant using affinity chromatography followed by ion exchange chromatography. Superantigen were produced in Escherichia coli and isolated from the periplasm as previously described (22).

Preparation of Ligand-coated Surfaces-- Maxisorb microtiter plates (NUNC A/S Denmark) were termed surface A and treated with 50 µl of PBS containing 10 µg/ml protein A (Amersham Pharmacia Biotech, Sweden) over night at +4 °C prior to use with antibodies. Plates were blocked for >1 h with PBS containing 2% BSA (Sigma Chemical Co., St. Louis, MO). Antibodies at 10 µg/ml in PBS + 0.2% BSA were diluting against a non-TCR-binding antibody at similar concentration to keep the level of protein A binding constant and thereby secure that the dilution factor was also represented on the surface. Antibody dilutions were incubated together with immobilized protein A for >2 h after which excess antibody was removed by washing. Alternatively, surface A was prepared by coating Maxisorb plates with serial dilutions of each superantigen (SEC3) variants. To ensure uniform coating at different concentrations, SEC3 molecules were diluted into PBS containing 5 µg/ml BSA. Surface B was prepared by coating antibodies directly on the surface of nunclon microwell plates (NUNC A/S Denmark). As above, antibodies were diluting against a non-TCR-binding antibody to keep the total concentration of protein (10 µg/ml) constant. TCR binding to surfaces A and B was compared by enzyme-linked immunosorbent assay (Fig. 3A). Antibody at 10 µg/ml was incubated with protein A-coated surface A or coated directly onto surface B. Serial dilutions of soluble TCRbeta (Vbeta 8.2+) (23) were thereafter added and left to bind for >1 h. Bound TCRbeta chain was detected using a biotinylated antibody against the Cbeta mixed with excess mouse serum to compete for unwanted binding to protein A. The assay was developed using horseradish peroxidase-conjugated streptavidin and the TMB-plus peroxidase substrate (Kem-En-Tech, Copenhagen, Denmark).

T Cell Stimulation-- A5 T cell hybridomas, expressing green fluorescence protein upon activation of the interkeulin-2 promoter, were stimulated for 4.0-4.5 h, and cellular activation was determined by the presence of intracellular green fluorescence protein. Fluorescent cells were detected by FACS and recorded as positive.

Mathematical Fitting of T Cell Responses-- Two-dimensional affinities are best expressed as molecules per µm2. The previously determined affinity constants (20)2 were therefore rescaled from moles per liter to molecules per µm3 prior to use in the fitting procedures (see Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Conversion of affinity binding constants

The average surface area of A5 T cell hybridomas was calculated from the cell diameter in growth medium (4 µm) and multiplied by a correction factor of 1.8 to compensate for the roughness of the cell surface (cell surface area = 4 × Pi  × (4 µm)2 × 1.8 = 360 µm2) (24). The total amount of TCR was determined by a calibrated FACS analyses using phycoerythrin-conjugated 2C11 antibody and calibrated PE-conjugated beads (BD Biosciences). Receptor density was determined by dividing the average surface area with the average number of receptors per cell ([TCR]total = 9200 molecules × cell-1/360 µm2 = 25 molecules/µm2). Ligand densities were determined by radioimmunoassays, as previously reported (20). Curves were fitted using the Sigma Plot software (SPSS Inc., Chicago, IL). Fits were done using the least-square Marquardt-Levenberg algorithm. T cell stimulation experiments were fitted directly using a combined expression of Equation 6 or Equations 6 and 7, as indicated in the text. Background values from unstimulated cells were subtracted prior to the fitting analysis. As an alternative to fac, fits could also be improved by assuming the density of TCR ([TCR]total) as variable (data not shown). However, these fits were not considered further because 1) fitted values of [TCR]total were significantly larger than measured values and 2) Kstim varied between different data sets and showed a strong mathematical dependence on [TCR]total in the fitting procedure.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Modeling T Cell Responsiveness by Laws of Mass Action-- T cells are activated when brought into contact with surfaces displaying ligands that interact with the TCR. The natural stimulus is other cells displaying antigenic pep·MHC complexes on their surface. However, purified TCR ligands coated onto surfaces composed of materials such as glass, agarose, or plastic (polystyrene) are generally found to be effective mimics of antigen-presenting cells (APC) and thus able to activate T cells. Regardless of surface, it appears reasonable to assume that laws of mass action guard initial contacts between TCR and ligand. Only few and relative specialized methods exist for measuring binding constants between molecules attached to surfaces (25-27). To bypass this difficulty, we propose to use affinities, i.e. equilibrium dissociation constants (Kd), measured in solution as basis for estimates of affinities in cellular interfaces.

On theoretical grounds, Bell (28) suggested that the affinity in solution (Kd(3D)) and the affinity in a cellular contact area (Kd(2D)) are related by a constant (sigma ), which is proportional to the height of the confined region in which binding occurs.
K<SUB>d(<UP>2D</UP>)</SUB>=&sfgr;<UP>·</UP>K<SUB>d(<UP>3D</UP>)</SUB> (Eq. 1)
Theoretically, the confinement region height has been predicted to be in the 1- to 10-nm range (29) and, furthermore, recently demonstrated experimentally by Dustin and colleagues (24, 30).

Having determined a relationship between the affinities measured in solution and the affinity between molecules attached to apposing surfaces, we are able to compute the density of bound receptors using the law of mass action (Equation 2) and the law of mass conservation (Equations 3 and 4),
[<UP>TCR</UP>]<UP> · </UP>[<UP>L</UP>]<UP>/</UP>[<UP>TCR/L</UP>]=K<SUB>d(<UP>2D</UP>)</SUB> (Eq. 2)

[<UP>TCR</UP>]<SUB><UP>total</UP></SUB>=[<UP>TCR</UP>]+[<UP>TCR/L</UP>] (Eq. 3)

[<UP>L</UP>]<SUB><UP>total</UP></SUB>=[<UP>L</UP>]+[<UP>TCR/L</UP>] (Eq. 4)
where [TCR], [L], and [TCR/L] are the density of free TCR, free ligand, and bound TCRs in the contact area, respectively. The total density of TCR and ligand ([L]total and [TCR]total) can be determined experimentally independent of the biological experiments. Equations 1-4 can be solved with respect to [TCR/L] and thus used to estimate the density of bound TCR in the contact zone. To translate binding events into response units, we assumed that subsequent cellular responses were directly proportional to the density of bound receptors expressed as,
R=K<SUB><UP>stim</UP></SUB><UP> · </UP>[<UP>TCR/L</UP>] (Eq. 5)
where R is the response level and Kstim is the proportionality constant expressing the increase in stimulation per TCR·ligand complex in the initial contact area. Thus, Equations 1-5 allows us to make a single equation (Equation 6), which describes the relationship between ligand density, receptor density, solution affinity, and cellular response.
R=K<SUB><UP>stim</UP></SUB><UP> ·</UP><FENCE>0.5<UP>·</UP><FENCE>(<UP>ETCR</UP></FENCE></FENCE>]<SUB><UP>total</UP></SUB>+[<UP>L</UP>]<SUB><UP>total</UP></SUB>+K<SUB>d(<UP>3D</UP>)</SUB><UP> · &sfgr;</UP>)+<RAD><RCD>([<UP>TCR</UP>]<SUB><UP>total</UP></SUB>+[<UP>L</UP>]<SUB><UP>total</UP></SUB>+K<SUB>d(<UP>3D</UP>)</SUB><UP> · &sfgr;</UP>)<SUP><UP>2</UP></SUP>−4<UP>·</UP>[<UP>TCR</UP>]<SUB><UP>total</UP></SUB><UP> · </UP>[<UP>L</UP>]<SUB><UP>total</UP></SUB></RCD></RAD><FENCE></FENCE> (Eq. 6)

Direct Fitting of T Cell Responses against Immobilized TCR Ligands-- Because the 2D-affinity model promises the ability to fit cellular responses directly, initial analysis could be done using existing datasets, which described activation of T cells as a function of ligand affinity and ligand density (20). The TCR ligand was a panel of antibodies of predetermined affinity against the variable domain of the TCR beta -chain, and T cell activation was determined by activation of the transcription factor of activated T cells (NFAT) (31). To become biologically active, the antibodies were immobilized on polystyrene plastic surfaces (surface A) coated with protein A. Ligand and receptor densities were determined independently of the biological assays by radioimmunoassays and FACS, respectively. Results in Fig. 1A demonstrate that antibody-coated surfaces were potent activators of T cells. Response curves showed that high TCR affinity activated most cells with a gradual drop in potency as the affinity of the antibody decreased. For antibodies of highest affinity, an optimum was reached after which the response started to decline. This decline was only evident at unphysiologically high ligand densities (>200 sites/µm2), and it therefore appeared reasonable to exclude the declining phase to simplify the modeling.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Direct fitting of T cell responses. A, stimulation of A5 T cells with serial dilutions of immobilized antibodies of varying TCR affinity. T cell were scored as positive according to activation of NFAT (see "Experimental Procedures" for details). The abscissa gives the number of TCR binding sites per µm2, and the ordinate gives the percentage of activated cells. Kd values are indicated for each response curve. B, open symbols represent the same data as in A. Lines represent best fits obtained using Equation 6. C, fitting of the same data set with Equations 6 and 7 combined, i.e. including the extra parameter fac that makes possible an estimation of the fraction of biologically active ligand on the presenting surface. Residuals are shown in the lower panels. Numerical results are presented in Table II. Shown is one representative example of five.

Response curves for the whole antibody panel were fitted globally to Equation 6 using the predetermined values for Kd(3D), TCR density, and ligand densities. Plotting the fitted lines together with the experimental data points (Fig. 1B) showed that the 2D-affinity model was able to model many of the observed features of the response curves. First, it described the relative ranking in potency of the ligands of different TCR affinity. Second, it described the increase in steepness of the response curves as the affinity of the ligand increases in contrast to the flatter profile of the low affinity response curves. In addition, statistical analysis (Table II) of the fits showed that the coefficient of determination (R2) was relatively close to unity and that the probability of being wrong was low (p < 0.05), which demonstrated that fits were of good quality and that the fitted values, sigma  and Kstim, were statistically well defined.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Fitting of T cell responses by the 2D-affinity model

On closer examination, the residuals (i.e. the difference between the theoretical and measured values; see bottom of Fig. 1B) showed that the 2D-affinity model was less capable of fitting the potency of high affinity antibodies, notably at low ligand density. One possible complication was that ligand density on the plastic surfaces was measured using soluble TCR molecules. Roughness of the plastic surface could exclude potential binding sites from T cell contact and thereby lower the density of biologically active ligand. Thus, we included an additional variable, fac, that described the fraction of active ligand on the plastic surface,
[<UP>L</UP>]<SUB><UP>ac</UP></SUB>=[<UP>L</UP>]<SUB><UP>total</UP></SUB> · f<SUB><UP>ac</UP></SUB> (Eq. 7)
Substituting the total ligand density, [L]total, with the density of active ligand, [L]ac, results in a new version of Equation 6 that was able to compensate for functional variability of immobilized ligands. Fitting of cellular responses revealed a significant improvement in the fits in the high affinity range (Fig. 1C), and ~57% of the plastic bound antibodies were estimated to be biological active (Table II). Residual plots showed that antibodies of high affinity were now fitted with equal quality as those of low affinity. The increase in fitting quality was also evident by statistical analysis where the R2 became closer to one while P values were still significantly small (Table II). Inclusion of fac had no effect on Kstim and caused a marginal 2-fold decrease of sigma  to 1.4 µm.

A sigma  value of 1.4 µm suggests that binding is confined to a relative large volume, several times the height of an antibody or a TCR. This contrasts theoretical predictions and the few experimental estimates of sigma  that were in the 1- to 10-nm range (discussed above). Regardless, the antibody-coated plastic surfaces were able to stimulate T cells with only a few ligands per µm2 demonstrating the high sensitivity of the experimental approach.

Direct Fitting of Cellular Responses of Superantigen-stimulated T cells-- To address the role of ligand topology and to test the generality of the 2D-affinity model we tested the fitting procedures on T cells stimulated by bacterial superantigens. The superantigens were variants of Staphylococcus enterotoxin C3 (SEC3), which had been selected for enhanced binding to TCR (20). The cellular assays were the same as that used with the antibodies: T cells were stimulated by serial dilutions of superantigens coated onto surface A, and cellular activation was determined by NFAT activity (Fig. 2A). The completeness of the data set was not sufficient to allow estimates of fac (data not shown). However, fitting of response curves using Equation 6 gave nice fits as judged by graphical (Fig. 2B) and statistical (Table II) analyses. As for the antibodies, sigma  was determined to be relative large, and Kstim was almost identical for the two sets of ligands (Table II). It therefore appeared that immobilized anti-TCR antibodies and superantigens were equal in their ability to activate T cells. The 10-fold higher sigma  values of the SEC3 variants relative to the antibodies could be explained by the inability of the relative hydrophobic surface A to co-align with the negatively charged cell surface. Precise membrane alignment has previously been suggested to be an important factor in enhancing the affinity between membrane proteins (24). The smaller size of SEC3 relative to the antibody would therefore make the interaction more sensitive to poor alignment of the apposing surfaces and hence increase the sigma  level.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Fitting of superantigen-mediated T cell responses. A, A5 T cells were stimulated with serial dilution of immobilized superantigens of varying TCR affinity. Results are presented as in Fig. 1. B, data sets are the same as in A. Lines represent best fits obtained using Equation 6. Residuals are shown in the lower panel. The results represent one experiment of four.

Change in Surface Chemistry Enhanced the Functional Affinity of TCR Ligands-- In their attempt to develop theoretical models for cellular adhesion, Bell and colleagues (32) predicted that the two-dimensional affinity of surface-bound proteins could be affected by electrostatic forces acting on the apposing surfaces. Also, a recent study has demonstrated that membrane roughness can modulate the effective affinity of membrane proteins (33). Taken together with the unexpectedly high sigma  values for antibodies and SEC3 variants on surface A, it appeared possible that chemical changes of the ligand-presenting surface could enhance the 2D-affinity of immobilized ligands. Accordingly, another plastic surface (surface B) was tested for its ability to present ligands to T cells. Surface B was chemically equivalent to the surface A but subjected to stronger irradiation (i.e. stronger oxidation) in the manufacturing process and therefore less hydrophobic and more electronegative. To exclude that surface charge had any direct effect on antibody affinity, the two surfaces were compared by a sandwich enzyme-linked immunosorbent assay approach. Antibody variants of medium affinity were immobilized on the two plastic surfaces and assayed for binding to soluble TCRbeta chain (Fig. 3A). TCR binding of the two surfaces were similar and fitted well to equations for one-to-one interactions demonstrating the intactness of the binding sites. To address the functional affinity, serial dilutions of each antibody were coated directly on surface B and used to stimulate T cells (Fig. 3B). The most prominent difference to the previous results was the relative small difference in potency among the high affinity antibodies indicating that ligand binding was approaching a plateau. Thus, making the ligand-presenting surface more electronegative clearly affected the functional affinity of the antibodies, and the appearance of a potency limit at lower affinity indicated an overall increase in 2D-affinity of the antibodies attached to surface B (see Fig. 5).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   The effect of the ligand-presenting surface on TCR affinity. A, test of binding of soluble TCRbeta chain to immobilized antibody. Antibody at 10 µg/ml was bound to surface A (open circles) or coated directly onto surfaces B (filled circles). Binding of serial dilutions of soluble TCRbeta chain was detected using a biotinylated antibody against the Cbeta . Results were fitted as 1:1 interactions (dotted lines and solid lines, respectively) as a test of homogeneity of the immobilized antibodies. B, A5 T cells were stimulated with serial dilution of antibodies of varying TCR affinity immobilized on surface B. Results are presented as in Fig. 1. C, same data set as in B. Lines represent best fits by Equations 6 and 7 combined. Residuals are shown in the lower panels. The results represent one experiment of five.

To test if the 2D-affinity model could simulate this phenomenon, response curves were fitted globally to Equations 6 and 7 using predetermined values for Kd(3D), [TCR]total, and [L]total (Fig. 3C). Fits were similar in quality to those obtained by the SEC3 variants as judged by the residuals (Fig. 3C) and the statistical analysis (Table II). The value of sigma  was estimated to be 98 nm, which corresponds to a 15-fold increase in 2D-affinity relative to surface A, and the theoretical curves showed signs of approaching an affinity limit. Kstim matched the previous results indicating that the biological activity of each receptor·ligand complex was the same on the two surfaces. The active fraction of antibodies dropped to ~20%, which was 3-fold lover than on surface A. Excluding protein A by attaching the antibodies directly to surface B would lead to a more random orientation of antibodies thus explaining the drop in activity. Nevertheless, the results showed that the 2D-affinity was dependent on the chemical composition of the presenting surface.

Direct Fitting of Cellular Responses of Pep·MHC-stimulated T Cells-- To further test the generality of the 2D-model, T cells were stimulated with purified pep·MHC. I-Ed was expressed as bivalent molecules fused to human Fcgamma 1 domains and subsequently loaded with HA peptide. The Fc domains made it possible to repeat the comparison of surface A and B using pep·MHC as immobilized ligand (Fig. 4A). As with the antibodies, I-Ed·HA complexes were more potent on surface B relative to surface A. Fitting of the 2D-affinity model to the cellular responses gave estimates of the confinement region heights of 1.5 µm and 46 nm, which matched the estimates for the antibodies. Thus, the surface-induced change in 2D-affinity seemed general and not linked to one particular ligand.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4.   Fitting of T cell responses against pep·MHC complexes. Stimulation of T cells with purified IEd·HA fusion proteins immobilized on surface A (closed symbols) or B (open symbols). Coated surfaces were prepared as in Fig. 1 and 3, respectively, and the response of A5 T cells is shown. Points indicate experimental values, and solid lines indicate fits. Numerical results are shown in Table II.

Estimating the Limits of TCR-ligand Affinity-- To further understand what role surface chemistry played in presenting ligands to T cells, it was of interest to compare the studies above to a T cell response against pep·MHC on a cell surface. Using the above estimates of confinement region heights for surface A and B and an independent estimate of the confinement region height of TCR·MHC interactions in a cellular interface (30), T cell responses were calculated corresponding to a panel of ligands ranging from 10-3 to 10-9 M in TCR affinity. Three conditions were simulated representing the surface of the APC, surface B, and surface A corresponding to sigma  values of 1.2, 46, and 1400 nm, respectively (Fig. 5A). As observed experimentally on surface B, the modeling demonstrated that beyond a certain limit additional increase in affinity did not lead to further stimulation due to saturation of the ligand. The modeling further predicted that the strongest binding antibody (Kd = 2.3 nM) on surface A was close to the experimental limit as previously suggested (20). Interestingly, as sigma  moved into the physiological range, the solution affinity limit got close to 10-5-10-6 M. The importance of this became evident when the theoretical limits were compared with the experimental limits observed for the solution TCR affinity of pep·MHC and bacterial superantigens (Fig. 5B). The limits predicted for the T cell/APC interface closely matched the observed limits for native TCR ligands. Thus, the 2D-affinity model implies that the low solution affinity of pep·MHC and superantigens to TCR equals maximal binding in the contact zone between the cell membranes.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Simulation of T cell responses. A, calculation of T cell responses against a panel of ligands ranging from 10-9 to 10-3 M in TCR affinity (i.e. from left to right 10-9, 10-8, 10-7, 10-6, 10-5, 10-4, and 10-3) assuming the three experimental conditions for the peptide·MHC presented in Fig. 4 (i.e. sigma  = 1400, 46, and 1.2 nM, as indicated). The exponent of each Kd value is shown next to the graphs. B, comparison of binding constants of native TCR ligands and predicted affinity limits for further increase in potency. Equilibrium binding constants of TCR interacting with pep·MHC (solid circles) and bacterial superantigen (open circles) were collected from the literature (14-16, 19, 22, 36, 45-52) or the result of own experiments (P. S. Andersen, R. A. Mariuzza, and K. Karjalainen, unpublished data). To facilitate comparison, only values recorded by optical biosensors at room temperature are presented. Hatched areas indicate approximate affinity limits for each modeled condition. Corresponding sigma  values are indicated next to each hatched area.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The important role of ligand binding strength in TCR signaling and hence T cell activation is well documented (1, 2). Central events in T cell development such as positive and negative selection in the thymus are in part determined by the binding strength of TCR ligands (14). Moreover, modified TCR ligands of sub-optimal binding have been found to act as partial agonist or antagonist (36, 37). The TCR is therefore capable of responding to a wide range of binding affinities resulting in differential cellular responses.

Using plastic-immobilized anti-TCR antibodies and superantigens of varying affinity and binding kinetics, we have previously reported that ligand-coated plastic surfaces were effective stimulators of T cells capable of inducing various responses in different types of T cells (20). Others have shown that many of the morphological responses observed to immobilized antibodies paralleled those observed during the early stages of physiological contact (38). Also, we observed that plastic-bound ligands were able to stimulate T cells at densities as low as 1-10 sites/µm2, which is close to the physiological limit of 0.2 sites/µm2 (30). Thus, immobilized TCR ligands on planar surfaces are able to functionally mimic pep·MHC complexes on the surface of APCs. Moreover, the use of planar surfaces coated with purified ligands is advantageous when addressing the role of TCR ligand affinity in TCR signaling, because the simplified nature of the stimulus excludes the contribution of co-stimulatory receptors. However, one important difference between ligand-coated surfaces and the native ligand-presenting surface is the inability of plastic-immobilized ligands to diffuse laterally (discussed below).

Previous studies have indicated that the potency of pep·MHC complexes on the surface of APCs correlates to TCR affinity (14-16, 19) and that stimulation of T cells follows the law of mass action (17, 18). It therefore appears possible that TCR signaling to a large extent is determined by the density of ligand-bound TCR in the contact zone. Based on the laws of mass and the concepts of 2D-affinity (26), we here propose a response calculus for T cell activation, called the 2D-affinity model, capable of modeling many of the features of T cell responses using predetermined values of TCR density, ligand density, and their corresponding affinity. The ability to simulate changes in ligand potency based solely on experimentally determined changes in solution affinity supports the assumption that changes in solution binding are translated into the cellular interface (see Equation 1). Furthermore, the assumption that the response was directly proportional to the density of ligand-bound TCR in the contact area allowed for an estimation of the specific potency of each ligand·receptor complex. Fitting of T cell responses against three types of immobilized ligands (i.e. antibodies, superantigens, and pep·MHC) indicated that the likelihood of cellular activation increased with 2-3% for each additional receptor·ligand complex formed per µm2 of contact.

Using ligands attached to phospholipid bilayers, Dustin and colleagues (24, 26) demonstrated that cell adhesion mechanisms of low solution affinity could produce contact areas of high physiological affinity presumably through precise alignment of the apposing membranes. Such a mechanism might explain that the potency of immobilized TCR ligands (antibodies and pep·MHC) was improved when increasing the negativity charge of the presenting surface. The chosen polystyrene surface was relatively hydrophobic in contrast to the cell surface and the phospholipid bilayer, which are covered with negatively charged sugar and phosphor groups, respectively. Making the polystyrene surface more electronegative, thus made it more similar to the biologically relevant surfaces. Better alignment of the T cell membrane with surface B relative to surface A could therefore explain the estimated 15- to 30-fold increase in two-dimensional affinity. In a more recent study, Dustin and colleagues (30) have reported a confinement region height of 1.2 nm for cellular interfaces involving 2B4 T cells and I-Ek·MCC complexes inserted into phospholipid bilayers. Relative to our estimates of ~1.5 µm and ~50 nm on plastic surfaces, this suggests an even better alignment of the T cell surface with the lipid bilayer is possible.

The ability of the 2D-affinity model to fit different experimental conditions allowed us to simulate T cell responses assuming different ligand-presenting surfaces. In agreement with our experimental data on surface B, the simulations show that for each simulated condition an affinity limit existed. Enhancing the affinity beyond that limit did not cause any further increase in stimulation due to lack of free ligand. Interestingly, we observed that, when the confinement region height became small, representing the APC, the theoretical affinity limit of 10-5-10-6 M matched the binding constants found for most pep·MHC ligand. It therefore appears reasonable to assume that the low affinity in solution of native TCR ligands (i.e. pep-MCH and superantigens) does not represent the physiological interaction. Rather, the affinity would be close to maximal in cellular interfaces and hence optimal for TCR signaling.

APCs need to carry in the range of 100-400 pep·MHC complexes to stimulate T cells (35, 39, 40). Because only a fraction of the cell surface participates in the initial contact with the T cell, few pep·MHC complexes are sufficient to start the signaling process. Taken together with the low solution affinity, this lead to the formulation of the low affinity/high sensitivity paradox (41): How could receptors of low affinity bind ligands at low density? The 2D-affinity model offers an explanation to this problem by indicating that TCRs are indeed of high intrinsic affinity in cellular interfaces and hence capable of recognizing low levels of ligands.

How can the increase in two-dimensional affinity be understood? Binding at equilibrium (the affinity) is equally determined by the rate by which molecules attach (the on-rate) and the rate by which they separate (the off-rate). Comparison of off-rates of adhesion molecules attached to membranes or in solution showed little difference (42). Any increase in affinity as a consequence of reduction in confinement region must therefore be linked to the on-rate. As the volume in which binding occurs gets smaller, the encounter frequency of two independently moving molecules increases. This also increases the chance of complex formation and thereby increases the on-rate. On the contrary, the off-rate is independent of concentration of the reactants and should therefore be insensitive to changes in confinement region size. Based on these simplified considerations, we propose that the increase in functional affinity presented in this study mainly arises from increasing the on-rate, i.e. the rate by which complexes form in the cellular interfaces.

Therefore, even though TCR ligands are of relatively high affinity in cellular contexts, they could still possess relatively fast dissociation rates, thus making serial triggering and kinetic proofreading possible. Nonetheless, because we did not observe any specific dependence on fast dissociation, it appears that if serial triggering is involved in TCR signaling, it must rely on the general dynamic nature of the immunological synapse (IS) rather than on the half-live of individual interactions. Furthermore, because stimulation did not correlate specifically to the off-rate, kinetic proofreading did not appear to be the determining factor. However, the results of the present study and the principles of kinetic proofreading are not mutually exclusive.

The kinetic proofreading model indicates that sub-optimal half-lives of TCR·ligand complexes leads to partial assembly of the initial signaling complex thereby causing a negative signal. The main purpose of the kinetic proofreading model is to explain differential signaling seen for peptide antagonists and positive and negative selecting peptides in the thymus (7, 8). These interactions are characterized by having very short half-lives typically of less than 1 s (14, 36) and thus below the range of half-lives used in this study. Our results can, therefore, be explained by assuming a relative short time (~1 s or less) for assembly of the full signaling complex. Prolonged contact would not lead to more simulation as such but maintain the signaling machinery in an active state. Higher ligand density or ligand affinity would then lead to stronger stimulation according to an increase in density of TCR·ligand complexes as observed.

Alternatively, as noted above, ligands immobilized on the plastic surface cannot move laterally and thus cannot cluster in the contact zone as otherwise observed during formation of the IS (30). In fact, the half-life of the ligand·TCR interaction was found to determine the ligand density of the IS, which subsequently correlated to the cellular response. Our experimental approach excludes the first step of synapse formation (i.e. active clustering of ligand), and the ligand density in the synapses would therefore not be able to exceed the density of ligand on the plastic surface. Cellular responses would therefore be strictly dependent on ligand density as observed. In support of this, we observed that the cellular response was maximal when the density of immobilized ligand matched the ligand density of ~200 ligands/µm2 found in synapses causing maximal cellular responses (see Fig. 1A).

Because ligands fixed to the plastic surface were able to activate T cells at densities of 1-10 ligands per µm2, the distance between each ligand must be relatively large, several times the extent of the ligand or the receptor. Lateral interactions, such as specific oligomerization of TCR·ligand complexes, are therefore unlikely to be required for early TCR signaling. Rather, each ligand-bound TCR must be able to transmit a signal independently of neighboring receptors. That TCRs work as independent signaling units is compatible with current hypotheses regarding TCR triggering such as (a) the size-exclusion model (43), which predicts that the TCR signaling cascade is activated by exclusion of large sized phosphatases, such as CD45, from the contact zone thereby enhancing ITAM phosphorylation or (b) the raft association model (44), which predicts that ligand-bound TCRs are actively recruited into lck-kinase rich membrane mini-domains called rafts. Although we cannot make any discrimination on the bases of our results, the former hypothesis seems the most attractive, because our results emphasize the importance of precise alignment of the ligand-presenting surface and the T cell membrane to achieve high affinity and hence maximal signaling.

    FOOTNOTES

* This research was supported in part by the Danish Medical Research Council (to C. G. and S. B), the Danish Cancer Society (to C. G.), and the National Institutes of Health (to R. A. M.). The Basel Institute for Immunology was founded and is supported by Hoffmann-LaRoche Ltd., Basel, Switzerland.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by fellowships from the Danish Natural Science Research council and the Danish Medical Research Council. To whom correspondence should be addressed: Symphogen A/S, Elektrovej, Bldg. 375, Lyngby DK-2800, Denmark. Tel.: 45-45-26-50-69; Fax: 45-45-26-50-60; E-mail: psa@symphogen.com.

Published, JBC Papers in Press, October 9, 2001, DOI 10.1074/jbc.M109396200

2 P. S. Andersen and K. Karjalainen, unpublished results.

    ABBREVIATIONS

The abbreviations used are: TCR, T cell receptor; MHC, major histocompatibility complex; pep·MHC, complexes of peptides bound to MHC molecules; ITAM, immunoreceptor tyrosine-based activation motif; PBS, phosphate-buffered saline; BSA, bovine serum albumin; FACS, fluorescence-activated cell sorting; APC, antigen-presenting cells; NFAT, transcription factor of activated T cells; SEC3, Staphylococcus enterotoxin C3; HA, hemagglutinin; IS, immunological synapse.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B., and Chien, Y. (1998) Annu. Rev. Immunol. 16, 523-544
2. Germain, R. N., and Stefanova, I. (1999) Annu. Rev. Immunol. 17, 467-522
3. Wange, R. L., and Samelson, L. E. (1996) Immunity 5, 197-205
4. Acuto, O., and Cantrell, D. (2000) Annu. Rev. Immunol. 18, 165-184
5. van der Merwe, P. A. (2000) Nat. Immunol. 1, 194-195
6. Valitutti, S., and Lanzavecchia, A. (1997) Immunol. Today 18, 299-304
7. Rabinowitz, J. D., Beeson, C., Lyons, D. S., Davis, M. M., and McConnell, H. M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1401-1405
8. McKeithan, T. W. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5042-5046
9. Bachmann, M. F., Salzmann, M., Oxenius, A., and Ohashi, P. S. (1998) Eur. J. Immunol. 28, 2571-2579
10. Gett, A. V., and Hodgkin, P. D. (2000) Nat. Immunol. 1, 239-244
11. Sykulev, Y., Vugmeyster, Y., Brunmark, A., Ploegh, H. L., and Eisen, H. N. (1998) Immunity 9, 475-483
12. Kersh, G. J., Kersh, E. N., Fremont, D. H., and Allen, P. M. (1998) Immunity 9, 817-826
13. Kalergis, A. M., Boucheron, N., Doucey, M. A., Palmieri, E., Goyarts, E. C., Vegh, Z., Luescher, I. F., and Nathenson, S. G. (2001) Nat. Immunol. 2, 229-234
14. Alam, S. M., Travers, P. J., Wung, J. L., Nasholds, W., Redpath, S., Jameson, S. C., and Gascoigne, N. R. (1996) Nature 381, 616-620
15. Baker, M. B., Gagnon, J. S., Biddison, E. W., and Wiley, C. D. (2000) Immunity 13, 475-484
16. Slansky, E. J., Rattis, M. F., Boyd, F. L., Fahmy, T., Jaffee, M. E., Schneck, P. J., Margulies, H. D., and Pardoll, M. D. (2000) Immunity 13, 529-538
17. Schodin, B. A., Tsomides, T. J., and Kranz, D. M. (1996) Immunity 5, 137-146
18. Sykulev, Y., Cohen, R. J., and Eisen, H. N. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11990-11992
19. Garcia, K. C., Radu, C. G., Ho, J., Ober, R. J., and Ward, E. S. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 6818-6823
20. Andersen, P. S., Geisler, C., Buus, S., Mariuzza, R. A., and Karjalainen, K. (2001) J. Biol. Chem. 276, 33452-33457
21. Wallny, H. J., Sollami, G., and Karjalainen, K. (1995) Eur. J. Immunol. 25, 1262-1266
22. Andersen, P. S., Lavoie, P. M., Sekaly, R. P., Churchill, H., Kranz, D. M., Schlievert, P. M., Karjalainen, K., and Mariuzza, R. A. (1999) Immunity 10, 473-483
23. Bentley, G. A., Boulot, G., Karjalainen, K., and Mariuzza, R. A. (1995) Science 267, 1984-1987
24. Dustin, M. L., Golan, D. E., Zhu, D. M., Miller, J. M., Meier, W., Davies, E. A., and van der Merwe, P. A. (1997) J. Biol. Chem. 272, 30889-30898
25. Piper, J. W., Swerlick, R. A., and Zhu, C. (1998) Biophys. J. 74, 492-513
26. Dustin, M. L., Ferguson, L. M., Chan, P. Y., Springer, T. A., and Golan, D. E. (1996) J. Cell Biol. 132, 465-474
27. Chesla, S. E., Selvaraj, P., and Zhu, C. (1998) Biophys. J. 75, 1553-1572
28. Bell, G. I. (1978) Science 200, 618-627
29. Lauffenburger, D. A., and Linderman, J. J. (1993) Receptors. Models for Binding, Trafficking and Signaling , Oxford University Press, New York
30. Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., and Dustin, M. L. (1999) Science 285, 221-227
31. Bot, A., Bot, S., Antohi, S., Karjalainen, K., and Bona, C. (1996) J. Immunol. 157, 3436-3442
32. Bell, G. I., Dembo, M., and Bongrand, P. (1984) Biophys. J. 45, 1051-1064
33. Williams, T. E., Nagarajan, S., Selvaraj, P., and Zhu, C. (2001) J. Biol. Chem. 276, 13283-13288
34. Deleted in proof
35. Reay, P. A., Matsui, K., Haase, K., Wulfing, C., Chien, Y. H., and Davis, M. M. (2000) J. Immunol. 164, 5626-5634
36. Lyons, D. S., Lieberman, S. A., Hampl, J., Boniface, J. J., Chien, Y., Berg, L. J., and Davis, M. M. (1996) Immunity 5, 53-61
37. Ding, Y. H., Baker, B. M., Garboczi, D. N., Biddison, W. E., and Wiley, D. C. (1999) Immunity 11, 45-56
38. Bunnell, S. C., Kapoor, V., Trible, R. P., Zhang, W., and Samelson, L. E. (2001) Immunity 14, 315-329
39. Demotz, S., Grey, H. M., and Sette, A. (1990) Science 249, 1028-1030
40. Harding, C. V., and Unanue, E. R. (1990) Nature 346, 574-576
41. Karjalainen, K. (1994) Curr. Opin. Immunol. 6, 9-12
42. Pierres, A., Benoliel, A. M., Bongrand, P., and van der Merwe, P. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 15114-15118
43. van der Merwe, P. A., McNamee, P. N., Davies, E. A., Barclay, A. N., and Davis, S. J. (1995) Curr. Biol. 5, 74-84
44. Lanzavecchia, A., Lezzi, G., and Viola, A. (1999) Cell 96, 1-4
45. Tissot, A. C., Ciatto, C., Mittl, P. R., Grutter, M. G., and Pluckthun, A. (2000) J. Mol. Biol. 302, 873-885
46. Pecorari, F., Tissot, A. C., and Pluckthun, A. (1999) J. Mol. Biol. 285, 1831-1843
47. Willcox, B. E., Gao, G. F., Wyer, J. R., Ladbury, J. E., Bell, J. I., Jakobsen, B. K., and van der Merwe, P. A. (1999) Immunity 10, 357-365
48. Garcia, K. C., Scott, C. A., Brunmark, A., Carbone, F. R., Peterson, P. A., Wilson, I. A., and Teyton, L. (1996) Nature 384, 577-581
49. Garcia, K. C., Tallquist, M. D., Pease, L. R., Brunmark, A., Scott, C. A., Degano, M., Stura, E. A., Peterson, P. A., Wilson, I. A., and Teyton, L. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 13838-13843
50. Redpath, S., Alam, S. M., Lin, C. M., O'Rourke, A. M., and Gascoigne, N. R. (1999) J. Immunol. 163, 6-10
51. Seth, A., Stern, L. J., Ottenhoff, T. H., Engel, I., Owen, M. J., Lamb, J. R., Klausner, R. D., and Wiley, D. C. (1994) Nature 369, 324-327
52. Malchiodi, E. L., Eisenstein, E., Fields, B. A., Ohlendorf, D. H., Schlievert, P. M., Karjalainen, K., and Mariuzza, R. A. (1995) J. Exp. Med. 182, 1833-1845


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/52/49125    most recent
M109396200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersen, P. S.
Right arrow Articles by Karjalainen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, P. S.
Right arrow Articles by Karjalainen, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK